NVCR | | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | Mar 01, 2024 | Sale | $16.03 | 1,679 | 26,909 | 160,938 | Mar 05, 2024, 04:08 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | Mar 04, 2024 | Sale | $16.01 | 840 | 13,448 | 160,098 | Mar 05, 2024, 04:08 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Feb 27, 2024 | Option Exercise | $16.30 | 102,249 | 1,666,659 | 219,867 | Feb 29, 2024, 04:43 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | Feb 27, 2024 | Option Exercise | $16.30 | 102,249 | 1,666,659 | 164,695 | Feb 29, 2024, 04:38 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | Feb 28, 2024 | Sale | $16.14 | 2,078 | 33,545 | 162,617 | Feb 29, 2024, 04:38 PM |
NVCR | | NovoCure Ltd | Puri Michal Nath | Chief Human Resources Officer | Feb 27, 2024 | Option Exercise | $16.30 | 71,574 | 1,166,656 | 109,167 | Feb 29, 2024, 04:36 PM |
NVCR | | NovoCure Ltd | Weinberg Uri | Chief Innovation Officer | Feb 27, 2024 | Option Exercise | $16.30 | 81,799 | 1,333,324 | 171,148 | Feb 29, 2024, 04:35 PM |
NVCR | | NovoCure Ltd | Leupin Nicolas | Chief Medical Officer | Feb 27, 2024 | Option Exercise | $16.30 | 51,124 | 833,321 | 51,124 | Feb 29, 2024, 04:33 PM |
NVCR | | NovoCure Ltd | Giladi Moshe | Chief Science Officer | Feb 27, 2024 | Option Exercise | $16.30 | 51,124 | 833,321 | 69,771 | Feb 29, 2024, 04:33 PM |
NVCR | | NovoCure Ltd | Ben Arye Barak | General Counsel | Dec 31, 2023 | Option Exercise | $12.69 | 128 | 1,624 | 35,323 | Feb 29, 2024, 04:30 PM |
NVCR | | NovoCure Ltd | Ben Arye Barak | General Counsel | Feb 27, 2024 | Option Exercise | $16.30 | 81,799 | 1,333,324 | 117,122 | Feb 29, 2024, 04:30 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Dec 31, 2023 | Option Exercise | $12.69 | 3 | 38 | 209,828 | Feb 29, 2024, 04:28 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Feb 27, 2024 | Option Exercise | $16.30 | 47,034 | 766,654 | 256,862 | Feb 29, 2024, 04:28 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Feb 28, 2024 | Sale | $16.14 | 2,303 | 37,177 | 254,559 | Feb 29, 2024, 04:28 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Nov 07, 2023 | Sale | $12.65 | 382 | 4,832 | 124,511 | Nov 08, 2023, 04:22 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Oct 31, 2023 | Option Exercise | $9.58 | 17,793 | 170,447 | 117,443 | Nov 02, 2023, 04:20 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Nov 02, 2023 | Option Exercise | $11.46 | 175 | 2,006 | 117,618 | Nov 02, 2023, 04:20 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Sep 01, 2023 | Sale | $21.82 | 883 | 19,265 | 99,650 | Sep 05, 2023, 04:24 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Sep 01, 2023 | Sale | $21.82 | 294 | 6,414 | 209,825 | Sep 05, 2023, 04:24 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Sep 01, 2023 | Sale | $21.82 | 273 | 5,956 | 124,893 | Sep 05, 2023, 04:23 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Aug 02, 2023 | Sale | $30.25 | 1,144 | 34,607 | 100,533 | Aug 04, 2023, 04:02 PM |
NVCR | | NovoCure Ltd | Weinberg Uri | Chief Innovation Officer | Jun 30, 2023 | Option Exercise | $35.28 | 305 | 10,760 | 89,349 | Jul 06, 2023, 04:15 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Jun 30, 2023 | Option Exercise | $35.28 | 366 | 12,912 | 210,119 | Jul 06, 2023, 04:14 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Jun 30, 2023 | Option Exercise | $35.28 | 367 | 12,948 | 125,166 | Jul 06, 2023, 04:14 PM |
NVCR | | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | Jun 30, 2023 | Option Exercise | $35.28 | 357 | 12,595 | 66,447 | Jul 06, 2023, 04:14 PM |
NVCR | | NovoCure Ltd | Ben Arye Barak | General Counsel | Jun 30, 2023 | Option Exercise | $35.28 | 288 | 10,161 | 35,195 | Jul 06, 2023, 04:13 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Jun 30, 2023 | Option Exercise | $35.28 | 367 | 12,948 | 101,677 | Jul 06, 2023, 04:13 PM |
NVCR | | NovoCure Ltd | Danziger Asaf | Chief Executive Officer | Jun 30, 2023 | Option Exercise | $35.28 | 367 | 12,948 | 13,989 | Jul 06, 2023, 04:12 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 03, 2023 | Sale | $76.16 | 5,291 | 402,959 | 63,490 | Mar 07, 2023, 04:52 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 07, 2023 | Sale | $75.16 | 8,318 | 625,205 | 56,599 | Mar 07, 2023, 04:52 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Mar 03, 2023 | Sale | $76.16 | 21,421 | 1,631,411 | 144,650 | Mar 07, 2023, 04:52 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Mar 03, 2023 | Sale | $76.16 | 25,635 | 1,952,346 | 231,860 | Mar 07, 2023, 04:51 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Mar 03, 2023 | Sale | $76.16 | 5,505 | 419,258 | 102,085 | Mar 07, 2023, 04:51 PM |
NVCR | | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | Mar 03, 2023 | Sale | $76.16 | 593 | 45,163 | 66,090 | Mar 07, 2023, 04:50 PM |
NVCR | | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | Mar 02, 2023 | Sale | $75.28 | 281 | 21,153 | 66,683 | Mar 06, 2023, 04:42 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Mar 02, 2023 | Sale | $75.28 | 937 | 70,535 | 99,038 | Mar 06, 2023, 04:41 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Mar 02, 2023 | Sale | $75.28 | 1,213 | 91,312 | 183,402 | Mar 06, 2023, 04:40 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Mar 02, 2023 | Sale | $75.28 | 1,055 | 79,418 | 95,007 | Mar 06, 2023, 04:40 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 02, 2023 | Sale | $75.28 | 844 | 63,535 | 58,144 | Mar 06, 2023, 04:37 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 03, 2023 | Sale | $77.64 | 2,059 | 159,859 | 67,893 | Mar 06, 2023, 04:37 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 02, 2023 | Sale | $75.38 | 4,107 | 309,578 | 59,296 | Mar 03, 2023, 04:13 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 01, 2023 | Sale | $76.36 | 1,684 | 128,594 | 63,095 | Mar 02, 2023, 05:01 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Mar 01, 2023 | Sale | $76.36 | 1,923 | 146,845 | 99,975 | Mar 02, 2023, 05:00 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Mar 01, 2023 | Sale | $76.36 | 2,198 | 167,845 | 96,062 | Mar 02, 2023, 04:55 PM |
NVCR | | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | Mar 01, 2023 | Sale | $76.36 | 755 | 57,654 | 66,964 | Mar 02, 2023, 04:51 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Mar 01, 2023 | Sale | $76.36 | 2,164 | 165,248 | 184,615 | Mar 02, 2023, 04:49 PM |
NVCR | | NovoCure Ltd | Ben Arye Barak | General Counsel | Jan 06, 2023 | Option Exercise | $62.31 | 150 | 9,346 | 17,152 | Jan 10, 2023, 04:20 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Jan 06, 2023 | Option Exercise | $62.31 | 66 | 4,112 | 74,442 | Jan 10, 2023, 04:18 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Jan 06, 2023 | Option Exercise | $62.31 | 102 | 6,355 | 165,126 | Jan 10, 2023, 04:17 PM |
NVCR | | NovoCure Ltd | Benaim Ely | Chief Medical Officer | Jan 06, 2023 | Option Exercise | $62.31 | 98 | 6,106 | 28,770 | Jan 10, 2023, 04:14 PM |
NVCR | | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | Jan 06, 2023 | Option Exercise | $62.31 | 108 | 6,729 | 55,594 | Jan 10, 2023, 04:13 PM |
NVCR | | NovoCure Ltd | Weinberg Uri | Chief Science Officer | Jan 05, 2023 | Sale | $102.81 | 10,089 | 1,037,296 | 49,050 | Jan 09, 2023, 06:24 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Jan 05, 2023 | Option Exercise | $66.60 | 74,716 | 4,976,351 | 53,984 | Jan 09, 2023, 06:21 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jan 05, 2023 | Sale | $108.00 | 387 | 41,796 | 82,843 | Jan 09, 2023, 06:20 PM |
NVCR | | NovoCure Ltd | Danziger Asaf | Chief Executive Officer | Jan 05, 2023 | Sale | $58.20 | 425,000 | 24,733,355 | 201,083 | Jan 09, 2023, 06:18 PM |
NVCR | | NovoCure Ltd | Danziger Asaf | Chief Executive Officer | Jan 06, 2023 | Option Exercise | $62.31 | 39 | 2,430 | 13,622 | Jan 09, 2023, 06:18 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Dec 02, 2022 | Option Exercise | $7.15 | 2,000 | 14,300 | 74,376 | Dec 05, 2022, 04:33 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Oct 13, 2022 | Sale | $76.01 | 6,754 | 513,372 | 43,626 | Oct 17, 2022, 04:35 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Oct 06, 2022 | Sale | $84.37 | 6,754 | 569,835 | 50,380 | Oct 07, 2022, 04:16 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Sep 29, 2022 | Sale | $77.35 | 6,754 | 522,422 | 57,134 | Sep 30, 2022, 04:20 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Sep 22, 2022 | Sale | $77.00 | 6,754 | 520,058 | 63,888 | Sep 26, 2022, 04:19 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 15, 2022 | Sale | $63.28 | 17,788 | 1,125,668 | 82,913 | Sep 19, 2022, 04:10 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 08, 2022 | Sale | $81.48 | 6,754 | 550,316 | 77,396 | Sep 13, 2022, 04:15 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 09, 2022 | Sale | $88.00 | 1,863 | 163,944 | 84,150 | Sep 12, 2022, 04:32 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 06, 2022 | Sale | $78.57 | 1,384 | 108,741 | 86,013 | Sep 07, 2022, 04:27 PM |
NVCR | | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | Sep 02, 2022 | Sale | $79.04 | 718 | 56,749 | 55,486 | Sep 06, 2022, 05:16 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Sep 02, 2022 | Sale | $79.04 | 885 | 69,948 | 72,376 | Sep 06, 2022, 05:15 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Sep 02, 2022 | Sale | $79.04 | 296 | 23,395 | 165,024 | Sep 06, 2022, 05:14 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Sep 02, 2022 | Sale | $79.04 | 269 | 21,261 | 83,230 | Sep 06, 2022, 05:12 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 01, 2022 | Sale | $77.43 | 14,212 | 1,100,476 | 101,146 | Sep 06, 2022, 04:19 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 02, 2022 | Sale | $79.04 | 584 | 46,158 | 87,397 | Sep 06, 2022, 04:19 PM |
NVCR | | NovoCure Ltd | Benaim Ely | Chief Medical Officer | Aug 03, 2022 | Sale | $73.73 | 5,959 | 439,328 | 34,068 | Aug 04, 2022, 04:32 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Aug 02, 2022 | Option Exercise | $70.20 | 7,122 | 499,964 | 73,261 | Aug 03, 2022, 04:45 PM |
NVCR | | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Aug 02, 2022 | Sale | $69.66 | 837 | 58,305 | 551,176 | Aug 03, 2022, 04:44 PM |
NVCR | | NovoCure Ltd | Benaim Ely | Chief Medical Officer | Aug 02, 2022 | Sale | $69.66 | 437 | 30,441 | 34,631 | Aug 03, 2022, 04:44 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Aug 02, 2022 | Sale | $69.66 | 414 | 28,839 | 102,193 | Aug 03, 2022, 04:44 PM |
NVCR | | NovoCure Ltd | Weinberg Uri | Chief Science Officer | Jul 05, 2022 | Option Exercise | $59.08 | 281 | 16,600 | 49,483 | Jul 07, 2022, 05:51 PM |
NVCR | | NovoCure Ltd | Ben Arye Barak | General Counsel | Jul 05, 2022 | Option Exercise | $59.08 | 144 | 8,507 | 17,002 | Jul 07, 2022, 05:50 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Jul 05, 2022 | Option Exercise | $59.08 | 251 | 14,828 | 66,139 | Jul 07, 2022, 05:49 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Jul 05, 2022 | Option Exercise | $59.08 | 218 | 12,878 | 165,320 | Jul 07, 2022, 05:48 PM |
NVCR | | NovoCure Ltd | Danziger Asaf | Chief Executive Officer | Jul 05, 2022 | Option Exercise | $59.08 | 276 | 16,305 | 13,583 | Jul 07, 2022, 05:48 PM |
NVCR | | NovoCure Ltd | Benaim Ely | Chief Medical Officer | Jul 05, 2022 | Option Exercise | $59.08 | 222 | 13,115 | 35,068 | Jul 07, 2022, 05:47 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Jul 05, 2022 | Option Exercise | $59.08 | 312 | 18,431 | 102,607 | Jul 07, 2022, 05:46 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 05, 2022 | Option Exercise | $59.08 | 312 | 18,431 | 83,499 | Jul 07, 2022, 05:45 PM |
NVCR | | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | Jul 05, 2022 | Option Exercise | $59.08 | 213 | 12,583 | 56,204 | Jul 07, 2022, 05:44 PM |
NVCR | | NovoCure Ltd | HILLEMAN JERYL L | Director | Jun 10, 2022 | Sale | $69.61 | 407 | 28,331 | 2,537 | Jun 16, 2022, 04:22 PM |
NVCR | | NovoCure Ltd | Benaim Ely | Chief Medical Officer | May 10, 2022 | Sale | $65.16 | 2,070 | 134,877 | 36,981 | May 12, 2022, 04:30 PM |
NVCR | | NovoCure Ltd | Benaim Ely | Chief Medical Officer | May 11, 2022 | Sale | $61.25 | 2,135 | 130,769 | 34,846 | May 12, 2022, 04:30 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Mar 03, 2022 | Option Exercise | $14.61 | 5,040 | 73,656 | 65,888 | Mar 11, 2022, 04:55 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 31, 2021 | Option Exercise | $154.01 | 3,717 | 572,455 | 85,625 | Mar 11, 2022, 04:54 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 09, 2022 | Sale | $71.19 | 3,669 | 261,196 | 83,187 | Mar 11, 2022, 04:54 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 07, 2022 | Sale | $69.55 | 5,294 | 368,198 | 84,389 | Mar 09, 2022, 04:56 PM |
NVCR | | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 08, 2022 | Sale | $70.10 | 2,481 | 173,918 | 81,908 | Mar 09, 2022, 04:56 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Mar 08, 2022 | Sale | $70.10 | 744 | 52,154 | 102,295 | Mar 09, 2022, 04:55 PM |
NVCR | | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | Mar 08, 2022 | Sale | $70.10 | 1,037 | 72,694 | 55,991 | Mar 09, 2022, 04:53 PM |
NVCR | | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Mar 08, 2022 | Sale | $70.10 | 2,923 | 204,902 | 165,102 | Mar 09, 2022, 04:52 PM |
NVCR | | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | Mar 08, 2022 | Sale | $70.10 | 759 | 53,206 | 60,848 | Mar 09, 2022, 04:51 PM |
NVCR | | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Mar 08, 2022 | Sale | $70.10 | 2,339 | 163,964 | 62,462 | Mar 09, 2022, 04:50 PM |
NVCR | | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Mar 08, 2022 | Sale | $70.10 | 2,385 | 167,188 | 552,013 | Mar 09, 2022, 04:48 PM |
NVCR | | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Mar 03, 2022 | Sale | $74.50 | 1,094 | 81,501 | 66,774 | Mar 07, 2022, 06:28 PM |